TITLE

An overview of human papillomaviruses and current vaccine strategies

AUTHOR(S)
Gnanamony, M.; Peedicayil, A.; Abraham, P.
PUB. DATE
January 2007
SOURCE
Indian Journal of Medical Microbiology;Jan2007, Vol. 25 Issue 1, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Cervical cancer is one of the most common cancers in women worldwide, particularly in developing countries. The viral origin of cervical cancer has been proven beyond any reasonable doubt. Persistent infection with certain subsets of human papillomaviruses is recognized as a necessary cause for the development of cervical cancer. Persistence of oncogenic HPVs, immunodeficiency, high HPV viral load and cofactors like smoking, multiple sex partners and poor nutrition predispose to cervical cancer. Prophylactic vaccines using HPV virus-like particles containing capsid protein L1 have shown protection against disease in animals and are currently undergoing clinical trials. Therapeutic vaccines using HPV E6 and E7 proteins are also being investigated for their ability to remove residual infection.
ACCESSION #
24450365

 

Related Articles

  • Vaccines for sexually transmitted infections. Rupp, Richard E.; Stanberry, Lawrence R.; Rosenthal, Susan L. // Pediatric Annals;Oct2005, Vol. 34 Issue 10, p818 

    STIs are responsible for significant human suffering and carry significant economic costs. Strategies to control STIs, such as screening programs and condoms, have had limited success. Vaccines offer an additional method that is not coitally related and does not depend on consistent use. The HPV...

  • Marketing HPV Vaccine. Rothman, Sheila; Rothman, David J. // JAMA: Journal of the American Medical Association;8/19/2009, Vol. 302 Issue 7, p781 

    The article examines the implications of the decision of Merck to market its human papillomavirus (HPV) vaccine Gardasil as an anticancer vaccine for adolescent health, physician practice and medical professionalism. An overview of the development and marketing of the vaccine is given. The...

  • HPV VACCINE MEETING THE CHALLENGE. FEEMSTER, KRISTEN; KAHN, JESSICA A. // Contemporary Pediatrics;Jun2010, Vol. 27 Issue 6, p34 

    This article explores human papillomavirus (HPV) infection and HPV vaccines, describes current indications and U.S. recommendations for the vaccines, and strategies that pediatricians can use for the successful implementation of HPV vaccine recommendations. Particular focus is given to the...

  • Comparing the HPV vaccines. Blamble, Deborah // Infectious Diseases in Children;Apr2010, Vol. 23 Issue 4, p53 

    This article compares the efficacy of human papillomavirus (HPV) vaccines.

  • PROPHYLACTIC HUMAN PAPILLOMA VIRUS VACCINES. VIKRANT C. SANGAR; B. B. GHONGANE // International Journal of Pharma & Bio Sciences;Jul-Sep2013, Vol. 4 Issue 3, pP-124 

    Human papillomaviruses are the primary etiologic agents of cervical cancer. Thus, cervical cancer and other Human papillomavirus associated malignancies might be prevented by Human papillomavirus vaccines. Currently, two Human papillomavirus L1 Virus -Like Particle vaccines namely Gardasil® -...

  • Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience. Heffernan, Margaret E.; Garland, Suzanne M.; Kane, Mark A. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p383 

    The article provides information on a study which examined the contributing factors to the initial slow uptake of hepatitis B virus (HBV) vaccine, and the extent of compliance with universal HBV vaccination. The common elements between HBV vaccine and human papillomavirus (HPV) vaccine are...

  • Cost Effectiveness of a Potential Vaccine for Human papillomavirus. Sanders, Gillian D.; Taira, Al V. // Emerging Infectious Diseases;Jan2003, Vol. 9 Issue 1, p37 

    Focuses on a study which evaluated the cost effectiveness of vaccinating adolescent girls for high risk human papillomavirus infections. Information on the study population; Analysis of potential vaccination strategies; Characteristics of the vaccines.

  • Vaccine Adherence in Adolescents. Lehmann, Corinne; Benson, Paul A. S. // Clinical Pediatrics;Oct2009, Vol. 48 Issue 8, p801 

    Although a number of routine and catch-up vaccinations are currently recommended for adolescents, coverage rates of these vaccines are currently suboptimal. Routine recommended immunizations for this cohort include vaccines for influenza, human papillomavirus, and meningococcal disease, as well...

  • Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Brotherton, Julia M. L.; Kaldor, John M.; Garland, Suzanne M. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p310 

    The article provides information on a study which proposed a possible multifaceted strategy to human papillomavirus (HPV) related surveillance in Australia following the adoption of a national HPV vaccination program. Main components discussed in detail are monitoring of vaccine coverage,...

  • HPV vaccination and the prevention of cervical cancer: a paradigm changing event. Markman, Maurie // Hem/Onc Today;4/25/2009, Vol. 10 Issue 8, p3 

    The author reflects on the importance of data regarding the effectiveness of two diferent human papillomavirus (HPV) vaccination strategies as a rational approach to prevent the development of cervical cancer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics